BIOMAT Database Logo BIOMAT Database Logo

In vitro activity of sulbactam/durlobactam against extensively drug-resistant Acinetobacter baumannii isolates belonging to South American major clones. 2021

Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
Universidade Federal de São Paulo (UNIFESP), Laboratório Alerta, Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina (EPM), São Paulo, SP, Brazil. Electronic address: carol.nodari@gmail.com.

UI MeSH Term Description Entries
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000151 Acinetobacter Infections Infections with bacteria of the genus ACINETOBACTER. Mimae Infections,Infections, Acinetobacter,Infections, Mimae,Acinetobacter Infection,Infection, Acinetobacter,Infection, Mimae,Mimae Infection
D013407 Sulbactam A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone. Bétamaze,CP-45899,Combactam,Penicillanic Acid Sulfone,Sulbactam Sodium,CP 45899,CP45899,Sodium, Sulbactam,Sulfone, Penicillanic Acid
D040981 Acinetobacter baumannii A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics. Bacterium anitratum

Related Publications

Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
September 2020, The Journal of antimicrobial chemotherapy,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
Sulbactam enhances the in vitro activity of sitafloxacin against extensively-drug resistant Acinetobacter baumannii.
October 2018, Experimental and therapeutic medicine,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China.
July 2020, The Journal of antimicrobial chemotherapy,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy.
August 2022, Antibiotics (Basel, Switzerland),
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant Acinetobacter baumannii.
December 2023, Antibiotics (Basel, Switzerland),
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
In vitro synergistic activity of the sulbactam/avibactam combination against extensively drug-resistant Acinetobacter baumannii.
July 2020, Journal of medical microbiology,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
September 2022, Journal of global antimicrobial resistance,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Isolates Belonging to Major Endemic Clones in South America.
January 2020, Frontiers in microbiology,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021.
September 2022, Antimicrobial agents and chemotherapy,
Carolina S Nodari, and Fernanda F Santos, and Mariana N L Kurihara, and Tiago B Valiatti, and Rodrigo Cayô, and Ana Cristina Gales
Activity of Sulbactam-Durlobactam and Comparators Against a National Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates From Greece.
January 2021, Frontiers in cellular and infection microbiology,
Copied contents to your clipboard!